HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shashi Bellam Selected Research

gimsilumab

1/2022Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shashi Bellam Research Topics

Disease

1COVID-19
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Inflammation (Inflammations)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2019
1Chronic Obstructive Pulmonary Disease (COPD)
11/2017

Drug/Important Bio-Agent (IBA)

1gimsilumabIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022
1CytokinesIBA
01/2019
1GoldIBA
11/2017

Therapy/Procedure

1Therapeutics
01/2022